Sns Financial Group, LLC Celcuity Inc. Transaction History

Sns Financial Group, LLC

  • $929 Million
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 02, 2021
SELL
$14.25 - $30.93 $106,305 - $230,737
-7,460 Reduced 35.43%
13,593 $326,000
Q3 2020

Nov 13, 2020
BUY
$5.1 - $7.07 $45,033 - $62,428
8,830 Added 72.24%
21,053 $122,000
Q4 2018

Feb 05, 2019
SELL
$20.87 - $29.05 $20,870 - $29,050
-1,000 Reduced 7.56%
12,223 $293,000
Q2 2018

Aug 14, 2018
BUY
$16.13 - $26.99 $213,286 - $356,888
13,223 New
13,223 $328,000

Others Institutions Holding CELC

# of Institutions
96
Shares Held
30.1M
Call Options Held
4.8K
Put Options Held
126K
View Full List

About Celcuity Inc.

CELC Quotes by TradingView
  • Ticker CELC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,941,300
  • Market Cap $235M
  • Description
  • Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...
More about CELC
Track This Portfolio

Track Sns Financial Group, LLC Portfolio

Follow Sns Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sns Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sns Financial Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email